Predict your next investment

Venture Capital
aminocapital.com

See what CB Insights has to offer

Investments

73

Portfolio Exits

10

Funds

9

About Amino Capital

Amino Capital is a venture firm based in Palo Alto, focusing on seed to growth-stage investments in big data, and data-driven technologies, including but not limited to IoT, medicine/genomics, AI/BI, drone/UAV, Fintech, security and infrastructure. The firm was founded in 2012 by a unique team of over 40 technology executives and innovators from Google, Facebook, Yahoo, Tencent, Alibaba, U of Chicago, Stanford U, Tsinghua U and et al. Since inception, the firm has invested over 100 seed, Series A and B stage companies, following with additional investments in their growth stage.

Amino Capital Headquarter Location

119 University Ave.

Palo Alto, California, 94301,

United States

650-799-4870

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Amino Capital News

Justpoint Grabs $1M Seed Funding Round

Sep 4, 2020

Justpoint announced today $1 million in seed funding led by Vivek Garipalli, founder and CEO of Clover Health, with participation from Amino Capital, Whoa Ventures and Harry Langenberg of Optima Tax Relief. Medical errors are currently the third leading cause of death in the US and often lead to the financial ruin of those who survive. The medical malpractice system exists to ease the lives of those afflicted and provide actionable feedback to doctors and hospitals-but this industry has one of the highest levels of dissatisfaction and distrust due to the perceived randomness of lawsuit payouts. Justpoint is redesigning the medical malpractice litigation process from both sides: by allowing plaintiffs that have legitimate claims to identify and retain the best attorney for their case, even if their claim would have been previously dismissed by attorneys who considered its value too low, and by quickly identifying claims that don't have legal merits to decrease frivolous lawsuits against healthcare providers and insurers. Justpoint's artificial intelligence platform offers consumers a faster and better understanding of the legal merits of their claim as well as an instant understanding of its likely settlement amount. With this technology, plaintiffs will be able to understand how each law firm performs for their specific type of claim. Additionally, Justpoint connects the two parties-helping plaintiffs find the best lawyer for their case, and helping law firms quickly find cases with merit. The investment will be used for scaling the company, including the hiring of more engineers and designers, as well as expanding customer acquisition channels, customer support, and developing partnerships with medical malpractice insurance companies and self-insured hospitals. "Justpoint has identified a big inefficient market in medical claims and malpractice that is ripe for disruption. Leveraging their deep experience in healthcare and technology, they have put together a brilliant team of engineers and scientists to turn their vision into reality. Their ability to leverage technologies such as AI, machine learning, and predictive analytics will add tremendous efficiencies and cut wasteful processes across the value chain, improving payouts and transparency for consumers and reducing search times and costs for law firms," said Harry Langenberg of Optima Tax Relief. To build these machine learning models, the company created a database of over 300,000 historic and active claims to quickly decipher the medical merits of a claim and improve the efficiency and transparency of the system. By introducing technology to this typically manual process, Justpoint is, for the first time, analyzing over 900 plaintiff law firms' performance in a scalable manner and increasing attorney's efficiencies by helping them focus on cases with merit. Ultimately, this platform's goal is to fulfill the medical malpractice system's intended goal of incentivizing the whole healthcare industry to strive for higher quality - providing a positive incentive for high-quality providers and negative incentives to providers who disproportionately harm patients. "Our goal is to ensure that the medical malpractice system fulfills its promise with the help of artificial intelligence," said Victor Bornstein, CEO & Co-founder at Justpoint. "We believe that better distinguishing lawsuits with merits and those without, as well as the future application of our technology in the clinical setting, will contribute to an improvement of health care provided to patients while providing a safety net for families that have suffered the consequences of medical mistakes. This additional capital will allow us to further impact the world of medical malpractice and meet the needs of our customers." About Justpoint Justpoint is an AI-first company redesigning the medical malpractice industry, offering consumers and law firms a faster and better way of understanding the legal merits of a claim as well as an instant prediction of the likely settlement amount. To advance the medical malpractice industry, Justpoint has put together a team with extensive achievements in healthcare technology, medical malpractice litigation, and artificial intelligence. For more information, visit Justpoint.com. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

Amino Capital Investments

73 Investments

Amino Capital has made 73 investments. Their latest investment was in Brown Foods as part of their Seed VC on June 6, 2022.

CBI Logo

Amino Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/15/2022

Seed VC

Brown Foods

$2.36M

Yes

1

6/10/2022

Seed VC

Unreal Milk

$2.36M

Yes

4

1/27/2022

Seed VC

Parthean

$1.1M

Yes

1

1/18/2022

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

10

12/22/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/15/2022

6/10/2022

1/27/2022

1/18/2022

12/22/2021

Round

Seed VC

Seed VC

Seed VC

Unattributed VC

Series A

Company

Brown Foods

Unreal Milk

Parthean

Subscribe to see more

Subscribe to see more

Amount

$2.36M

$2.36M

$1.1M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

4

1

10

10

Amino Capital Portfolio Exits

10 Portfolio Exits

Amino Capital has 10 portfolio exits. Their latest portfolio exit was Human Longevity on June 21, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/21/2022

Acq - Pending

$99M

1

5/2/2022

Reverse Merger

$99M

3

8/25/2021

Acquired

7

3/30/2021

Acquired

Subscribe to see more

Subscribe to see more

10

3/15/2021

Acquired

Subscribe to see more

Subscribe to see more

10

Date

6/21/2022

5/2/2022

8/25/2021

3/30/2021

3/15/2021

Exit

Acq - Pending

Reverse Merger

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

1

3

7

10

10

Amino Capital Fund History

9 Fund Histories

Amino Capital has 9 funds, including Amino Capital III 2005.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/30/2020

Amino Capital III 2005

$1.45M

1

9/6/2018

Amino Capital III

Subscribe to see more

Subscribe to see more

$99M

10

4/24/2017

Amino Capital Special Opportunity Fund II

Subscribe to see more

Subscribe to see more

$99M

10

9/29/2016

Amino Capital II

Subscribe to see more

Subscribe to see more

$99M

10

2/4/2016

Amino Capital Special Opportunity Fund

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

6/30/2020

9/6/2018

4/24/2017

9/29/2016

2/4/2016

Fund

Amino Capital III 2005

Amino Capital III

Amino Capital Special Opportunity Fund II

Amino Capital II

Amino Capital Special Opportunity Fund

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$1.45M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

Amino Capital Team

1 Team Member

Amino Capital has 1 team member, including current Founding Partner, Huican Zhu.

Name

Work History

Title

Status

Huican Zhu

Founding Partner

Current

Name

Huican Zhu

Work History

Title

Founding Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.